NYU Hospital for Joint Diseases, New York, NY, USA.
J Orthop Trauma. 2012 Sep;26(9):545-9. doi: 10.1097/BOT.0b013e318238becb.
To compare the efficacy of anesthetic type on clinical outcomes after operative treatment of distal radius fractures.
Retrospective review of prospectively collected data.
Academic medical center.
One hundred eighty-seven patients with a distal radius fracture (OTA type 23) were identified within a registry of 600 patients.
Patients with operative distal radius fractures underwent open reduction and internal fixation with a volarly applied plate and screws under regional or general anesthesia.
Clinical, radiographic, and patient-based functional outcomes were recorded at routine postoperative intervals. Complications were recorded.
One hundred eighty-seven patients met inclusion criteria and had a minimum of 1-year follow-up. There were no differences between the groups with regard to patient demographics or fracture types treated. At both 3 and 6 months post surgery, pain was diminished among those patients who received a regional block. Wrist and finger range of motion for patients who received regional versus general anesthesia was improved at all follow-up points. Patients who received regional anesthesia also had higher functional scores as measured by the Disabilities of the Arm, Shoulder and Hand at 3 months (P = 0.04) and 6 months (P = 0.02).
Patients who are candidates should be offered regional anesthesia when undergoing repair of a displaced distal radius fracture.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
比较麻醉类型对桡骨远端骨折手术治疗后临床结果的影响。
前瞻性收集数据的回顾性研究。
学术医疗中心。
在 600 例患者的登记处中确定了 187 例桡骨远端骨折(OTA 类型 23)患者。
接受手术治疗的桡骨远端骨折患者采用经皮掌侧入路切开复位内固定,使用钢板和螺钉固定,麻醉方式为区域阻滞麻醉或全身麻醉。
记录常规术后随访间隔的临床、影像学和基于患者的功能结果。记录并发症。
187 例患者符合纳入标准,并进行了至少 1 年的随访。两组患者在患者人口统计学和治疗骨折类型方面无差异。在术后 3 个月和 6 个月时,接受区域阻滞麻醉的患者疼痛减轻。与接受全身麻醉的患者相比,接受区域阻滞麻醉的患者腕关节和手指活动范围在所有随访点均得到改善。接受区域阻滞麻醉的患者在术后 3 个月(P = 0.04)和 6 个月(P = 0.02)时,其手臂、肩部和手部功能障碍评分(DASH)更高。
对于接受桡骨远端骨折修复的患者,应向符合条件的患者提供区域阻滞麻醉。
治疗性 III 级。有关证据水平的完整说明,请参阅作者指南。